Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

cns Press Releases

  + XML/RSS  



By Ventac Partners
Clinical Network Services (CNS) an integrated service consultancy focused on product development and Ventac Partners, a life science consulting firm, today announced that they have signed a cooperative partnership agreement to provide joint services

By SMi Group Ltd
SMi is proud to announce that Giulio Maria Pasinetti and Paul Francis have joined the programme for its 13th annual Clinical Trials in CNS conference.

By SMi Group Ltd
SMi is delighted to announce its 13th annual Clinical Trials in CNS Conference that will be held in London. With an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society.

By SMi Group
SMi is pleased to announce Oxford Biomedica will be presenting their investigations around gene therapies for Parkinson’s disease in clinical trials at this years Clinical Trials in CNS event which is taking place on 18-19 November, London UK

By SMi Group
Clinical Trials in CNS taking place in London, UK, 18th & 19th November 2013

By SMi Group
Join fellow industry professionals at SMi's Future CNS Clinical Development Driven by Innovation, Superiority and Market Access Evaluation: The Payer Centric Approach taking place on 8th July 2013, Central London

By SMi Group
This event will discuss the latest developments in preclinical discover, clinical trial design, clinical trial management and the latest developments in neurodegenerative treatments and will feature talks from top pharmaceutical companies.

By SMi Group
Paving the way of using AD biomarkers as supportive evidence of disease modifying treatment effects

By SMi Group
SMi are proud to present their 7th annual ADMET conference on 9th & 10th July 2012 in London,

By TCG Lifesciences Limited
TCG Lifesciences Limited (TCGLS) has announced that it has entered into a strategic agreement with JSW Lifesciences (JSW), a full services EU based CRO, to strengthen its R&D offerings in the area of Central Nervous System (CNS).

All Press Releases

By Ventac Partners
Clinical Network Services (CNS) an integrated service consultancy focused on product development and Ventac Partners, a life science consulting firm, today announced that they have signed a cooperative partnership agreement to provide joint services

By SMi Group Ltd
SMi is proud to announce that Giulio Maria Pasinetti and Paul Francis have joined the programme for its 13th annual Clinical Trials in CNS conference.

By SMi Group Ltd
SMi is delighted to announce its 13th annual Clinical Trials in CNS Conference that will be held in London. With an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society.

By SMi Group
The highly anticipated Clinical Trials in CNS conference returns to London in less than one month with a two day content packed agenda featuring new approaches taken in this field towards a number of neurodegenerative disorders.

By SMi Group
SMi is pleased to announce Oxford Biomedica will be presenting their investigations around gene therapies for Parkinson’s disease in clinical trials at this years Clinical Trials in CNS event which is taking place on 18-19 November, London UK

By SMi Group
Clinical Trials in CNS taking place in London, UK, 18th & 19th November 2013

By SMi Group
Join fellow industry professionals at SMi's Future CNS Clinical Development Driven by Innovation, Superiority and Market Access Evaluation: The Payer Centric Approach taking place on 8th July 2013, Central London

By SMi Group
Join fellow industry professionals at SMi's Masterclass - CNS Orphan Diseases - the alternative route in CNS taking place on 9th April 2013, Central London

By SMi Group
Join fellow industry professionals at SMi's Masterclass - CNS Orphan Diseases- the alternative route in CNS taking place on 9th April 2013, Central London

By SMi Group
This event will discuss the latest developments in preclinical discover, clinical trial design, clinical trial management and the latest developments in neurodegenerative treatments and will feature talks from top pharmaceutical companies.

By SMi Group
Paving the way of using AD biomarkers as supportive evidence of disease modifying treatment effects

By SMi Group Ltd
Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK.

By SMi Group
SMi are proud to present their 7th annual ADMET conference on 9th & 10th July 2012 in London,

By TCG Lifesciences Limited
TCG Lifesciences Limited (TCGLS) has announced that it has entered into a strategic agreement with JSW Lifesciences (JSW), a full services EU based CRO, to strengthen its R&D offerings in the area of Central Nervous System (CNS).

By Visiongain
A new report by London-based business information company visiongain predicts that world pharma clinical trial services revenues will reach $32.73bn in 2015. Revenues for those companies (CROs) totalled $21.69bn in 2010.

By Fast Market Research
Recently published research from Business Insights, "The CNS Market Outlook to 2016", is now available at Fast Market Research

By SMi Group Ltd
SMi Group is proud to announce its 10th annual Clinical Trials in CNS conference, which will be held in London on 23rd & 24th November 2011.

By Fast Market Research
Fast Market Research recommends "Dementia Therapeutics - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

By SMi Group
Identify the key issues responsible for the low success rates in CNS drug discovery and development, to highlight strategies being developed to overcome these issues and to discuss how these may change the landscape for drug development.

By www.insiderslab.com
Insider Trading of Real Estate Sector Touched the Lowest Level of the Year

By SMi Group
SMi Biomarkers - LAST CHANCE TO ATTEND! Dieses Bild im Großformat speichern (openPR) - Biomarkers Summit Biomarker Discovery, Validation and Qualification 31st January to 1st February 2011, Crowne Plaza - The City, London, United Kingdom

By SMi Group
SMi's CPD accredited masterclass will be delivered through a combination of discussions, case studies and lectures, designed to promote a hands-on and creative approach to CNS medicines research, visit the corresponding link below to register online.

By Fast Market Research
Recently published research from GlobalData, "Huntington's Disease - Pipeline Assessment and Market Forecasts to 2017", is now available at Fast Market Research

By SMi Group
SMi present their 4th annual Biomarkers Summit Monday 31st January & Tuesday 1st February 2011, Crowne Plaza City, Central London, UK Sponsored by: Caprotec, Cell Signalling Technology, Genstruct, Millipore, RBM, Quest Diagnostics

By Pharma IQ
Suicidality Monitoring in Clinical Trials will be one of the topics widely discussed at Optimising Clinical Development in CNS, taking place in London, 15-16 of March 2011.

By Fast Market Research
Fast Market Research recommends "Insomnia - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

By Fast Market Research
New Pharmaceuticals market report from GlobalData: "Major Depressive Disorder (MDD) - Pipeline Assessment and Market Forecasts to 2017"

By SMi Group
SMi present their 4th annual... Biomarkers Summit Discovery, Validation and Qualification Monday 31st January & Tuesday 1st February 2011 Crowne Plaza City, Central London, UK Sponsored by: Caprotec Genstruct RBM

By Bharatbook
Bharatbook added a new report on "Central Nervous System (CNS) Biomarkers: Technologies and Global Markets" which assess the global CNS biomarker market and make forecasts from 2010 to 2015.

By Fast Market Research
New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

By SMi Group Ltd.
Monday 31st January & Tuesday 1st February 2011 Crown Plaza City, London, www.smi-online.co.uk/preclinical-biomarkers.asp

By reports-research.com
Schizophrenia played a prominent role at this year's American Psychiatric Association Annual Meeting due to the prevailing high level of unmet need.

By Bharatbook
Sanofi-Aventis has announced the withdrawal of its US and EU applications for the approval of eplivanserin as a treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.

By John Thompson
Are you in need of a cnc plasma cutter? Are you not sure what cnc plasma cutter to buy? Perhaps you need plasma cutting equipment for a diy (do it yourself) project

By Bharatbook
Bharatbook.com added a new report on "The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis" gives clinical trials about CNS in pharma companies.

By Genetic Engineering & Biotechnology News
The blood-brain barrier (BBB) remains a major obstacle to the successful delivery of drugs to treat central nervous system (CNS) disorders, reports Genetic Engineering and Biotechnology News (GEN)



Page:
  • 1

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share